-
Je něco špatně v tomto záznamu ?
Up-regulation of CD163 expression in subpopulations of blood monocytes after kidney allograft transplantation
L. Čurnová, K. Mezerová, V. Švachová, M. Fialová, M. Novotný, E. Čečrdlová, O. Viklický, I. Stříž
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Grantová podpora
NV15-26883A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- alografty MeSH
- antigeny diferenciační myelomonocytární krev MeSH
- biologické markery krev MeSH
- CD antigeny krev MeSH
- dospělí MeSH
- interleukin-10 metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- makrofágy imunologie metabolismus MeSH
- mladiství MeSH
- mladý dospělý MeSH
- monocyty imunologie metabolismus MeSH
- receptory buněčného povrchu krev MeSH
- rejekce štěpu krev etiologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- transplantace ledvin * MeSH
- upregulace MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
M2 macrophages expressing CD163 are known to suppress immune responses but have been also found in biopsies of patients with chronic kidney allograft injury associated with interstitial fibrosis. The aim of our study was to evaluate the expression of CD163 in blood monocytes, precursors of tissue macrophages, in kidney allograft recipients with uncomplicated outcome (n=94) compared with those developing acute rejection (n=44). Blood samples were collected before the transplantation and at 1 week, 1 month and 1 year. The expression of CD163 increased during the first week after the transplantation not only in classical (CD14+CD16-) but also in intermediate (CD14+CD16+) and nonclassical (CD14lowCD16+) monocytes in all patients regardless of their rejection status. In patients developing acute rejection, higher pre-transplant expression of CD163 on blood monocytes was found. In vitro experiments confirmed strong induction of membrane CD163 on monocytes together with CD206 (an alternative marker of M2 macrophages) in response to IL-10. We assume from our data that dramatic upregulation of CD163 by peripheral blood monocytes may have a pathophysiological role in early phases after kidney allograft transplantation and high pre-transplant expression of CD163 on blood monocytes might be involved in events leading to acute rejection.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028127
- 003
- CZ-PrNML
- 005
- 20211129135923.0
- 007
- ta
- 008
- 211105s2020 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934531 $2 doi
- 035 __
- $a (PubMed)32901498
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Čurnová, Lenka $7 xx0267477 $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 245 10
- $a Up-regulation of CD163 expression in subpopulations of blood monocytes after kidney allograft transplantation / $c L. Čurnová, K. Mezerová, V. Švachová, M. Fialová, M. Novotný, E. Čečrdlová, O. Viklický, I. Stříž
- 504 __
- $a Literatura
- 520 9_
- $a M2 macrophages expressing CD163 are known to suppress immune responses but have been also found in biopsies of patients with chronic kidney allograft injury associated with interstitial fibrosis. The aim of our study was to evaluate the expression of CD163 in blood monocytes, precursors of tissue macrophages, in kidney allograft recipients with uncomplicated outcome (n=94) compared with those developing acute rejection (n=44). Blood samples were collected before the transplantation and at 1 week, 1 month and 1 year. The expression of CD163 increased during the first week after the transplantation not only in classical (CD14+CD16-) but also in intermediate (CD14+CD16+) and nonclassical (CD14lowCD16+) monocytes in all patients regardless of their rejection status. In patients developing acute rejection, higher pre-transplant expression of CD163 on blood monocytes was found. In vitro experiments confirmed strong induction of membrane CD163 on monocytes together with CD206 (an alternative marker of M2 macrophages) in response to IL-10. We assume from our data that dramatic upregulation of CD163 by peripheral blood monocytes may have a pathophysiological role in early phases after kidney allograft transplantation and high pre-transplant expression of CD163 on blood monocytes might be involved in events leading to acute rejection.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a alografty $7 D064591
- 650 _2
- $a CD antigeny $x krev $7 D015703
- 650 _2
- $a antigeny diferenciační myelomonocytární $x krev $7 D015214
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a rejekce štěpu $x krev $x etiologie $7 D006084
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukin-10 $x metabolismus $7 D016753
- 650 12
- $a transplantace ledvin $7 D016030
- 650 _2
- $a makrofágy $x imunologie $x metabolismus $7 D008264
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a monocyty $x imunologie $x metabolismus $7 D009000
- 650 _2
- $a receptory buněčného povrchu $x krev $7 D011956
- 650 _2
- $a upregulace $7 D015854
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mezerová, Kristýna $7 xx0266990 $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Švachová, Veronika $7 xx0254626 $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Fialová, Martina $7 xx0230845 $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Novotný, Marek $7 xx0213626 $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Brabcová, Eva $7 xx0212445 $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Viklický, Ondřej, $d 1966- $7 nlk20050170291 $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Stříž, Ilja, $d 1958- $7 jn20000402309 $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, č. 5 (2020), s. 885-896
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32901498 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20211105 $b ABA008
- 991 __
- $a 20211123104359 $b ABA008
- 999 __
- $a ok $b bmc $g 1728736 $s 1148672
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 69 $c 5 $d 885-896 $e 20200909 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- GRA __
- $a NV15-26883A $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20211105